[Treatment of refractory epilepsy with dipropyl acetate].
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001288:Attention / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D004328:Drive / Q000187:drug effects; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014631:Valerates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D000927:Anticonvulsants; D014631:Valerates
Die Behandlung therapieresistenter Epilepsien mit Dipropylacetat.